Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The MURAL collection of prostate cancer patient-derived xenografts enables discovery through preclinical models of uro-oncology
Gail P. Risbridger, Ashlee K. Clark, Laura H. Porter, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 51

Showing 1-25 of 51 citing articles:

Patient‐derived xenograft model in cancer: establishment and applications
Ao Gu, Jiatong Li, Mengyao Li, et al.
MedComm (2025) Vol. 6, Iss. 2
Open Access | Times Cited: 5
Experimental in vitro, ex vivo and in vivo models in prostate cancer research
Verena Sailer, Gunhild von Amsberg, Stefan Duensing, et al.
Nature Reviews Urology (2022) Vol. 20, Iss. 3, pp. 158-178
Closed Access | Times Cited: 33
Enhancer RNA promotes resistance to radiotherapy in bone-metastatic prostate cancer by m6A modification
Yu Zhao, Simeng Wen, Hang Li, et al.
Theranostics (2023) Vol. 13, Iss. 2, pp. 596-610
Open Access | Times Cited: 22
Low-dose carboplatin modifies the tumor microenvironment to augment CAR T cell efficacy in human prostate cancer models
L. H. Porter, Joe Jiang Zhu, Natalie Lister, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 20
High-throughput microfluidic droplets in biomolecular analytical system: A review
Lexiang Zhang, Rokshana Parvin, Mingshuo Chen, et al.
Biosensors and Bioelectronics (2023) Vol. 228, pp. 115213-115213
Closed Access | Times Cited: 19
Modeling the Tumor Microenvironment and Cancer Immunotherapy in Next-Generation Humanized Mice
Anna Chen, Ines Neuwirth, Dietmar Herndler‐Brandstetter
Cancers (2023) Vol. 15, Iss. 11, pp. 2989-2989
Open Access | Times Cited: 18
FOXA2 rewires AP-1 for transcriptional reprogramming and lineage plasticity in prostate cancer
Zifeng Wang, Scott L. Townley, Songqi Zhang, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 7
CDK9 inhibition inhibits multiple oncogenic transcriptional and epigenetic pathways in prostate cancer
Razia Rahman, Muhammed H. Rahaman, Adrienne R. Hanson, et al.
British Journal of Cancer (2024) Vol. 131, Iss. 6, pp. 1092-1105
Open Access | Times Cited: 5
The Role of ERα and ERβ in Castration-Resistant Prostate Cancer and Current Therapeutic Approaches
Nur Erysha Sabrina Jefferi, Asma’ ‘Afifah Shamhari, Nur Khayrin Zulaikha Noor Azhar, et al.
Biomedicines (2023) Vol. 11, Iss. 3, pp. 826-826
Open Access | Times Cited: 12
Unraveling the Global Proteome and Phosphoproteome of Prostate Cancer Patient-Derived Xenografts
Zoi E. Sychev, Abderrahman Day, Hannah E. Bergom, et al.
Molecular Cancer Research (2024) Vol. 22, Iss. 5, pp. 452-464
Open Access | Times Cited: 4
Co‐targeting BET, CBP, and p300 inhibits neuroendocrine signalling in androgen receptor‐null prostate cancer
Nicholas Choo, Shivakumar Keerthikumar, Susanne Ramm, et al.
The Journal of Pathology (2024) Vol. 263, Iss. 2, pp. 242-256
Open Access | Times Cited: 4
Development and characterization of patient-derived salivary gland cancer organoid cultures
Gerben Lassche, Wim van Boxtel, Tilly Aalders, et al.
Oral Oncology (2022) Vol. 135, pp. 106186-106186
Open Access | Times Cited: 17
Preclinical Models of Neuroendocrine Prostate Cancer
Alessia Cacciatore, Domenico Albino, Carlo V. Catapano, et al.
Current Protocols (2023) Vol. 3, Iss. 5
Open Access | Times Cited: 10
Left out in the cold: Moving beyond hormonal therapy for the treatment of immunologically cold prostate cancer with CAR T cell immunotherapies
Laura H. Porter, Sophie Harrison, Gail P. Risbridger, et al.
The Journal of Steroid Biochemistry and Molecular Biology (2024) Vol. 243, pp. 106571-106571
Open Access | Times Cited: 3
Lipid-metabolism-focused CRISPR screens identify enzymes of the mevalonate pathway as essential for prostate cancer growth
Gio Fidelito, Izabela Todorovski, Leonie A. Cluse, et al.
Cell Reports (2025) Vol. 44, Iss. 4, pp. 115470-115470
Open Access
Reprogramming of Androgen Receptor Activity in Castration-resistant Prostate Cancer is Shaped by Truncated Variants
Mitchell G. Lawrence, Shivakumar Keerthikumar, Scott L. Townley, et al.
European Urology Focus (2025)
Open Access
Preclinical Models of Neuroendocrine Neoplasia
Andrew J. H. Sedlack, Kimia Saleh-Anaraki, Suresh Kumar, et al.
Cancers (2022) Vol. 14, Iss. 22, pp. 5646-5646
Open Access | Times Cited: 16
Personalized Medicine for Prostate Cancer: Is Targeting Metabolism a Reality?
Gio Fidelito, Matthew J. Watt, Renea A. Taylor
Frontiers in Oncology (2022) Vol. 11
Open Access | Times Cited: 15
The future of patient-derived xenografts in prostate cancer research
Mitchell G. Lawrence, Renea A. Taylor, Georgia B. Cuffe, et al.
Nature Reviews Urology (2023) Vol. 20, Iss. 6, pp. 371-384
Open Access | Times Cited: 8
Patient-derived castration-resistant prostate cancer model revealed CTBP2 upregulation mediated by OCT1 and androgen receptor
Daisuke Obinata, Ken‐ichi Takayama, Mitchell G. Lawrence, et al.
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 3
Prostate Cancer Brain Metastasis: Review of a Rare Complication with Limited Treatment Options and Poor Prognosis
Kobisha Rajeswaran, Kaitlin Muzio, Juan Briones, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 14, pp. 4165-4165
Open Access | Times Cited: 14
PET imaging of new target CDK19 in prostate cancer
Dong Dai, Yu Jiang, Ting Huang, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2023) Vol. 50, Iss. 11, pp. 3452-3464
Closed Access | Times Cited: 8
Novel frontiers in urogenital cancers: from molecular bases to preclinical models to tailor personalized treatments in ovarian and prostate cancer patients
Giada De Lazzari, Alena Opattová, Sabrina Arena
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 2
Recent advances in basic research on prostate cancer: Where we are heading?
Daisuke Obinata, Yasutaka Yamada, Takayuki Sumiyoshi, et al.
International Journal of Urology (2024)
Open Access | Times Cited: 2
Patient-Derived Organoid Model in the Prediction of Chemotherapeutic Drug Response in Colorectal Cancer
Minglu Hao, Zhipeng Cao, Zhiwei Wang, et al.
ACS Biomaterials Science & Engineering (2022) Vol. 8, Iss. 8, pp. 3515-3525
Closed Access | Times Cited: 11
Page 1 - Next Page

Scroll to top